CHARLES F THOMAS, M.D.
Osteopathic Medicine at 1 St, Rochester, MN

License number
Minnesota 36433
Category
Osteopathic Medicine
Type
Internal Medicine
License number
Minnesota 36433
Category
Osteopathic Medicine
Type
Pulmonary Disease
Address
Address
200 1St St SW, Rochester, MN 55905
Phone
(507) 284-2511

Organization information

See more information about CHARLES F THOMAS at bizstanding.com

Mayo Clinic - Charles F Thomas MD

200 1 St SW #W4, Rochester, MN 55905

Categories:
Internal Medicine Physicians & Surgeons
Phone:
(507) 284-2511 (Phone)

Professional information

Charles F Thomas Photo 1

Dr. Charles F Thomas, Rochester MN - MD (Doctor of Medicine)

Specialties:
Critical Care Medicine, Pulmonology
Address:
Mayo Clinic
200 1St St SW, Rochester 55905
(507) 284-2511 (Phone)
Certifications:
Critical Care Medicine, 2010, Internal Medicine, 1995, Pulmonary Disease, 1999
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Mayo Clinic
200 1St St SW, Rochester 55905
Park Nicollet Methodist Hospital
6500 Excelsior Blvd, Saint Louis Park 55426
Education:
Medical School
University Of Texas Medical Branch At Galveston
Graduated: 1992
Mayo Grad School Med/Mayo Fndn


Charles Francis Thomas Photo 2

Charles Francis Thomas, Rochester MN

Specialties:
Internal Medicine, Critical Care Medicine, Pulmonary Disease
Work:
Mayo Medical School
200 1St St Sw, Rochester, MN 55905
Education:
The University of Texas at Galveston (1992)


Charles Thomas Photo 3

Cdc2 Protein Kinase From Pneumocystis Carinii

US Patent:
6015700, Jan 18, 2000
Filed:
Jun 8, 1998
Appl. No.:
9/093522
Inventors:
Andrew H. Limper - Rochester MN
Edward B. Leof - Rochester MN
Charles F. Thomas - Rochester MN
Michael P. Gustafson - Rochester MN
Assignee:
Mayo Foundation for Medical Education and Research - Rochester MN
International Classification:
C12N 900, C12P 2106, C07H 1700
US Classification:
435183
Abstract:
A nucleic acid and corresponding polypeptide that aids in the regulation of the cell cycle in Pneumocystis carinii is described. Antibodies generated against a unique carboxyl-terminus region of the polypeptide have specific binding affinity for P. carinii Cdc2 polypeptide and are benificial in diagnosing and monitoring P. carinii infection in patients. Expression of P. carinii Cdc2 polypeptide in cdc2-mutant yeast and other cdc2-mutant organisms provides a for model for studying the life cycle of P. carinii and for identifying novel therapeutics.


Charles Thomas Photo 4

Method For Identifying Inhibitors Of Cdc2 Protein Kinase From Pneumocystis Carinii

US Patent:
5863741, Jan 26, 1999
Filed:
Jun 13, 1997
Appl. No.:
8/874347
Inventors:
Andrew H. Limper - Rochester MN
Edward B. Leof - Rochester MN
Charles F. Thomas - Rochester MN
Michael P. Gustafson - Rochester MN
Assignee:
Mayo Foundation for Medical Education and Research - Rochester MN
International Classification:
C12Q 100, G01N 3353, C12N 912, C12N 900
US Classification:
435 76
Abstract:
A nucleic acid and corresponding polypeptide that aids in the regulation of the cell cycle in Pneumocystis carinii is described. Antibodies generated against a unique carboxyl-terminus region of the polypeptide have specific binding affinity for P. carinii Cdc2 polypeptide and are beneficial in diagnosing and monitoring P. carinii infection in patients. Expression of P. carinii Cdc2 polypeptide in cdc2-mutant yeast and other cdc2-mutant organisms provides a useful model for studying the life cycle of P. carinii and for identifying novel therapeutics.